133 related articles for article (PubMed ID: 8485109)
21. 4'-Methyl derivatives of 5-MOP and 5-MOA: synthesis, photoreactivity, and photobiological activity.
Gia O; Anselmo A; Conconi MT; Antonello C; Uriarte E; Caffieri S
J Med Chem; 1996 Oct; 39(22):4489-96. PubMed ID: 8893844
[TBL] [Abstract][Full Text] [Related]
22. A study of the relationship between photosensitizing and therapeutic activity of 4,5',8-trimethylpsoralen, and its major metabolite 4,8-dimethyl, 5'-carboxypsoralen.
Pathak MA; Marciani MS; Guiotto A; Rodighiero G
J Invest Dermatol; 1983 Dec; 81(6):533-9. PubMed ID: 6644095
[TBL] [Abstract][Full Text] [Related]
23. Interstrand crosslinks in DNA of phage lambda after exposure to 8-methoxypsoralen and trimethylpsoralen in the presence of light.
Cassuto E; Carter DM
J Invest Dermatol; 1979 Sep; 73(3):236-8. PubMed ID: 469276
[TBL] [Abstract][Full Text] [Related]
24. The time of onset and duration of 5-methoxypsoralen photochemoprotection from UVR-induced DNA damage in human skin.
Chadwick CA; Potten CS; Cohen AJ; Young AR
Br J Dermatol; 1994 Oct; 131(4):483-94. PubMed ID: 7947200
[TBL] [Abstract][Full Text] [Related]
25. Reversible binding of 5- and 8-methoxypsoralen to human serum proteins (albumin) and to epidermis in vitro.
Artuc M; Stuettgen G; Schalla W; Schaefer H; Gazith J
Br J Dermatol; 1979 Dec; 101(6):669-77. PubMed ID: 534612
[TBL] [Abstract][Full Text] [Related]
26. Action spectra of topical psoralens: a re-evaluation.
Cripps DJ; Lowe NJ; Lerner AB
Br J Dermatol; 1982 Jul; 107(1):77-82. PubMed ID: 7104210
[TBL] [Abstract][Full Text] [Related]
27. Evidence for uptake of 8-methoxypsoralen and 5-methoxypsoralen by cellular nuclei.
Sasaki M; Meguro F; Kumazawa E; Fujita H; Kakishima H; Sakata T
Mutat Res; 1988 Jan; 197(1):51-8. PubMed ID: 3336374
[TBL] [Abstract][Full Text] [Related]
28. 5-Methoxypsoralen enhances plasma melatonin concentrations in the male rat: non-noradrenergic-mediated stimulation and lack of effect in pinealectomized animals.
Mauviard F; Pévet P; Forlot P
J Pineal Res; 1991 Aug; 11(1):35-41. PubMed ID: 1941505
[TBL] [Abstract][Full Text] [Related]
29. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
30. A new micronized 5-methoxypsoralen preparation. Higher bioavailability and lower UVA dose requirement.
Treffel P; Makki S; Humbert P; Khaldoun H; Agache P
Acta Derm Venereol; 1992; 72(1):65-7. PubMed ID: 1350152
[TBL] [Abstract][Full Text] [Related]
31. Validation of a microdialysis-gas chromatographic-mass spectrometric method to assess 8-methoxypsoralen in psoriatic patient dermis.
Leveque N; Muret P; Mary S; Bérard M; Makki S; Pierre Kantelip J; Humbert P
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):119-27. PubMed ID: 12383487
[TBL] [Abstract][Full Text] [Related]
32. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
Aubin F; Makki S; Humbert P; Muret P; Agache P
Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
[TBL] [Abstract][Full Text] [Related]
33. Food-induced increase in bioavailability of 5-methoxypsoralen.
Ehrsson H; Wallin I; Ros AM; Eksborg S; Berg M
Eur J Clin Pharmacol; 1994; 46(4):375-7. PubMed ID: 7957526
[TBL] [Abstract][Full Text] [Related]
34. Spectrofluorimetric determination of 5-methoxypsoralen pharmacokinetic in patients' serum.
Saïd A; Makki S; Muret P; Toubin G; Humbert P; Millet J
Exp Dermatol; 1997 Apr; 6(2):57-63. PubMed ID: 9209885
[TBL] [Abstract][Full Text] [Related]
35. Tracing the Photoaddition of Pharmaceutical Psoralens to DNA.
Diekmann J; Theves I; Thom KA; Gilch P
Molecules; 2020 Nov; 25(22):. PubMed ID: 33182821
[TBL] [Abstract][Full Text] [Related]
36. 5-Methoxypsoralen inhibits 6-hydroxylation of melatonin in the rat.
Mauviard F; Raynaud F; Geoffriau M; Claustrat B; Pévet P
Biol Signals; 1995; 4(1):32-41. PubMed ID: 7550582
[TBL] [Abstract][Full Text] [Related]
37. Concentration of trimethylpsoralen in blood and skin after oral administration.
Ros AM; Wennersten G; Wallin I; Ehrsson H
Photodermatol; 1988 Jun; 5(3):121-5. PubMed ID: 3174490
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of 5-methoxypsoralen by Saccharomyces cerevisiae.
Morichetti E; Ceragioli C; Cundari E; Del Carratore R; Fiorio R; Bronzetti G; Averbeck D
Photochem Photobiol; 1991 Nov; 54(5):689-95. PubMed ID: 1798745
[TBL] [Abstract][Full Text] [Related]
39. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood.
Shephard SE; Zogg M; Burg G; Panizzon RG
Arch Dermatol Res; 1999 Sep; 291(9):491-9. PubMed ID: 10541879
[TBL] [Abstract][Full Text] [Related]
40. Effect on topical 5-methoxypsoralen on tumorigenesis induced in albino and pigmented hairless mouse skin by UV irradiation.
Reeve VE; Greenoak GE; Boehm-Wilcox C; Canfield PJ; Gallagher CH
J Photochem Photobiol B; 1990 May; 5(3-4):343-57. PubMed ID: 2115915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
